AgeX Therapeutics, Inc. (AGE)

Operating Income Growth

13.02%

TTM · Period ending:

AGE logo

AGE Operating Income Growth

Year-over-year change vs the same period a year earlier

Latest reported13.02%
AGE TTM Operating Income YoY % (-11.69% → 13.02%)
High-resolution chart · PNG

AGE operating income growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

AgeX Therapeutics, Inc. Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
13.0183%
11.761%
-40.908%
-55.1497%
-84.1196%
-103.3488%
-71.1647%
-84.0504%
-64.0862%
-42.96%
-42.7957%
-15.8924%
-2.6726%
9.1947%
13.2355%
18.0879%
23.1576%
20.1761%
24.665%
21.2157%
20.8718%
22.6647%
15.033%
17.1275%
2.5487%
-16.7899%
-11.6852%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.